Agency for Surrogacy and Fertility Solutions, Inc. – Trademark Portfolio
Entity Type: 03
Agency for Surrogacy and Fertility Solutions, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 3 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include TRUEMATCH, DELIVERING DREAMS, and THE FERTILITY AGENCY. The owner is based in La Crescenta, CA.
La Crescenta, CA 91214
Showing of trademarks Trademarks
Trademark Classifications
Agency for Surrogacy and Fertility Solutions, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Agency for Surrogacy and Fertility Solutions, Inc. have?
Agency for Surrogacy and Fertility Solutions, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Agency for Surrogacy and Fertility Solutions, Inc. file in?
Agency for Surrogacy and Fertility Solutions, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Agency for Surrogacy and Fertility Solutions, Inc.'s most well-known trademarks?
Agency for Surrogacy and Fertility Solutions, Inc.'s registered trademark portfolio includes well-known marks such as TRUEMATCH, DELIVERING DREAMS, and THE FERTILITY AGENCY. These are among 3 currently registered trademarks in the portfolio.
What is Agency for Surrogacy and Fertility Solutions, Inc.'s trademark registration success rate?
Agency for Surrogacy and Fertility Solutions, Inc. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.